Transparency as a means to increase clinical trial enrollment

Drug Information Journal

Volumn 44, Issue 3, 2010, Pages 265-270

  Godlew, Barbara J ^a,b   Furlong, Patricia ^c  

^a DIA CTR Working Group   (United States)

^b FAIRE Company LLC   (United States)

^c Parent Project Muscular Dystrophy   (United States)

Author keywords

Cancer; ClinicalTrials.gov; Duchenne muscular dystrophy; Patient advocate; Recruitment

Indexed keywords

CLINICAL PROTOCOL; CLINICAL TRIAL; HUMAN; PATIENT ADVOCACY; PATIENT PARTICIPATION; POPULATION SIZE; PRIORITY JOURNAL; REGISTER; SHORT SURVEY;

EID: 78650183807     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286151004400308     Document Type: Short Survey

References (15)

1. Hanley B, Truesdale A, King A, Elbourne D, Chalmers I. Involving consumers in designing, conducting, and interpreting randomised controlled trials: questionnaire survey. BMJ. 2001;322(3):519-523.
2. Misconceptions and lack of awareness greatly reduce recruitment for cancer clinical trials. Health Care News. Harris Interactive. 2001;1(3):1-3.
3. Basch EM, Thaler HT, Shi W, et al. Use of information resources by patients with cancer and their companions. Cancer. 2004;100:2476-2483.
4. Lawsin CR, Borrayo EA, Edwards R, et al. Community readiness to promote Latinas' participation in breast cancer prevention clinical trials. Health Soc Care Community. 2007;15(4):369-378.
5. Kilgore ML, Goldman DP. Drug costs and out-ofpocket spending in cancer clinical trials. Contemp Clin Trials. 2008;29(1):1-8.
6. Cheung AM, Lee Y, Kapral M, et al. Barriers and motivations for women to participate in cardiovascular trials. J Obstet Gynaecol Can. 2008; 30(4):332-337.
7. Commis RL, Miller JD, Aldigè CR, et al. Public attitudes toward participation in cancer clinical trials. J Clin Oncol. 2000;21:830-835.
8. There are many reasons why people are reluctant to participate in clinical trials. Health Care News. Harris Interactive. 2002;2(7):1-4.
9. Goodare H, Smith R. The rights of patients in research. BMJ. 1995;310:1277-1278.
10. Entwistle VA, Renfrew M, Yearley S, Forrester J, Lamont T. Incorporating lay perspectives: advantages for research. BMJ. 1998;316:463-466.
11. UK Department of Health. Research Governance Framework for Health and Social Care. 2nd ed. 2005. Section 2.2.6:8.
12. Eastern Cooperative Oncology Group. Cancer clinical trial partnerships for researchers and advocates. http://www.ecog.org/general/Partners Brochure.pdf. Accessed December 17, 2008.
13. Entwistle V, Calnan M, Dieppe P. Consumer involvement in setting the health services research agenda: persistent questions of value. J Health Serv Res Policy. 2008;13(3):76-81.
14. Horton R. Errors admitted over falsified US cancer data. Lancet. 1994;343:1029.
15. Altman LK. Health officials apologize for problems with falsified data in cancer study. New York Times. April 14, 1994.